Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Dulac

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
International Journal of Cardiology|May 21, 2017
Prevalence of early repolarisation pattern in childrenPhilippe Maury, Céline Authenac, Anne Rollin, et al.
Molecular Genetics & Genomic Medicine|October 21, 2021
A +3 variant at a donor splice site leads to a skipping of the MYH11 exon 32, a recurrent RNA defect causing Heritable Thoracic Aortic Aneurysm and Dissection and/or Patent Ductus ArteriosusBertrand Chesneau, Aurélie Plancke, Guillaume Rolland, et al.
Frontiers in Cardiovascular Medicine|December 20, 2023
Advancing paediatric cardiac imaging: a comprehensive analysis of the feasibility and accuracy of a novel 3D paediatric transoesophageal probeClément Karsenty, Khaled Hadeed, Pierrick Pyra, et al.
European Journal of Human Genetics : EJHG|January 8, 2021
Parental mosaicism in Marfan and Ehlers-Danlos syndromes and related disordersBertrand Chesneau, Aurélie Plancke, Guillaume Rolland, et al.
Journal of Clinical Medicine|April 28, 2023
Primary Non-Aortic Lesions Are Not Rare in Marfan Syndrome and Are Associated with Aortic Dissection Independently of AgeJean Sénémaud, Marine Gaudry, Elisabeth Jouve, et al.
Molecular Genetics & Genomic Medicine|March 11, 2020
Clinical and genetic data of 22 new patients with SMAD3 pathogenic variants and review of the literatureBertrand Chesneau, Thomas Edouard, Yves Dulac, et al.
International Journal of Cardiology|September 14, 2016
Corrigendum to "FUTURE-2: Results from an open-label, long-term safety and tolerability extension study using the pediatric FormUlation of bosenTan in pUlmonary arterial hypeRtEnsion" [Int. J. Cardiol. 202 (2016) 52-58]Rolf M F Berger, Sheila G Haworth, Damien Bonnet, et al.
International Journal of Cardiology|September 21, 2015
FUTURE-2: Results from an open-label, long-term safety and tolerability extension study using the pediatric FormUlation of bosenTan in pUlmonary arterial hypeRtEnsionRolf M F Berger, Sheila G Haworth, Damien Bonnet, et al.
Archives of Cardiovascular Diseases|July 13, 2010
Rationale and design of a randomized clinical trial (Marfan Sartan) of angiotensin II receptor blocker therapy versus placebo in individuals with Marfan syndromeDelphine Detaint, Philippe Aegerter, Florence Tubach, et al.
Health and Quality of Life Outcomes|January 20, 2021
Impact of a transition education program on health-related quality of life in pediatric patients with congenital heart disease: study design for a randomised controlled trialOscar Werner, Charlene Bredy, Kathleen Lavastre, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
International Journal of Cardiology|May 21, 2017
Prevalence of early repolarisation pattern in childrenPhilippe Maury, Céline Authenac, Anne Rollin, et al.
Molecular Genetics & Genomic Medicine|October 21, 2021
A +3 variant at a donor splice site leads to a skipping of the MYH11 exon 32, a recurrent RNA defect causing Heritable Thoracic Aortic Aneurysm and Dissection and/or Patent Ductus ArteriosusBertrand Chesneau, Aurélie Plancke, Guillaume Rolland, et al.
Frontiers in Cardiovascular Medicine|December 20, 2023
Advancing paediatric cardiac imaging: a comprehensive analysis of the feasibility and accuracy of a novel 3D paediatric transoesophageal probeClément Karsenty, Khaled Hadeed, Pierrick Pyra, et al.
European Journal of Human Genetics : EJHG|January 8, 2021
Parental mosaicism in Marfan and Ehlers-Danlos syndromes and related disordersBertrand Chesneau, Aurélie Plancke, Guillaume Rolland, et al.
Journal of Clinical Medicine|April 28, 2023
Primary Non-Aortic Lesions Are Not Rare in Marfan Syndrome and Are Associated with Aortic Dissection Independently of AgeJean Sénémaud, Marine Gaudry, Elisabeth Jouve, et al.
Molecular Genetics & Genomic Medicine|March 11, 2020
Clinical and genetic data of 22 new patients with SMAD3 pathogenic variants and review of the literatureBertrand Chesneau, Thomas Edouard, Yves Dulac, et al.
International Journal of Cardiology|September 14, 2016
Corrigendum to "FUTURE-2: Results from an open-label, long-term safety and tolerability extension study using the pediatric FormUlation of bosenTan in pUlmonary arterial hypeRtEnsion" [Int. J. Cardiol. 202 (2016) 52-58]Rolf M F Berger, Sheila G Haworth, Damien Bonnet, et al.
International Journal of Cardiology|September 21, 2015
FUTURE-2: Results from an open-label, long-term safety and tolerability extension study using the pediatric FormUlation of bosenTan in pUlmonary arterial hypeRtEnsionRolf M F Berger, Sheila G Haworth, Damien Bonnet, et al.
Archives of Cardiovascular Diseases|July 13, 2010
Rationale and design of a randomized clinical trial (Marfan Sartan) of angiotensin II receptor blocker therapy versus placebo in individuals with Marfan syndromeDelphine Detaint, Philippe Aegerter, Florence Tubach, et al.
Health and Quality of Life Outcomes|January 20, 2021
Impact of a transition education program on health-related quality of life in pediatric patients with congenital heart disease: study design for a randomised controlled trialOscar Werner, Charlene Bredy, Kathleen Lavastre, et al.
Pageof 9